Andrew T. Serafini, Ph.D. / 施安德，博士
Partner
Publications Drug Approval Considerations and Patent Linkage System in China
Andrew Serafini is co-author of “Drug Approval Considerations and Patent Linkage System in China,” as featured in the American Bar Association’s Third Edition of ” Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio.”
Contact